The worldwide CAR T-cell therapy market is experiencing substantial growth, driven by rising demand for advanced cancer treatment options. This rapid expansion is fueled by factors such as the acceptance of CAR T-cell therapies for various indications, advancements in production technologies, and growing research and development programs. Moreover